The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NSABP FC-10: A phase Ib study of pembrolizumab (pembro) in combination with pemetrexed (pem) and oxaliplatin (oxali) in patients with chemo-refractory metastatic colorectal cancer (mCRC).
 
John C. Krauss
Research Funding - Abbvie (Inst); Abbvie (Inst); ACCRU (Inst); Alliance for Clinical Trials in Oncology (Inst); Alliance for Clinical Trials in Oncology (Inst); Alliance for Clinical Trials in Oncology (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Cardiff Oncology; Daiichi Sankyo/Arqule (Inst); Hutchison MediPharma (Inst); Ignyta (Inst); Isofol Medical (Inst); Novartis (Inst); NSABP FOUNDATION (Inst); NSABP Foundation (Inst); Pfizer (Inst); Tempest Therapeutics (Inst); Tempest Therapeutics (Inst)
 
Greg Yothers
Employment - Mountainview Pediatrics (I)
Consulting or Advisory Role - Orbus Therapeutics
 
Thomas J. George
Consulting or Advisory Role - Pfizer; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Abbott (I); Bristol Myers Squibb (I); GlaxoSmithKline (I); Johnson & Johnson (I); Novartis (I)
Consulting or Advisory Role - New Century Health
 
Atrayee Basu Mallick
Stock and Other Ownership Interests - Alexion Pharmaceuticals (I); BMS (I); Pfizer (I)
Consulting or Advisory Role - Bayer; Novartis
Research Funding - Advenchen Laboratories (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Pyramid Biosciences (Inst); Rgenix (Inst); The Academic GI Cancer Consortium (Inst); TRACON Pharma (Inst)
 
James J. Lee
Consulting or Advisory Role - Regeneron
 
Shannon Leigh Huggins-Puhalla
Consulting or Advisory Role - Abbvie; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Pfizer (Inst)
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Samuel A. Jacobs
Employment - Exact Sciences
 
Norman Wolmark
No Relationships to Disclose